BFSP2-AS1

Across TCGA pan-cancer cohorts, BFSP2-AS1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of BFSP2-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where BFSP2-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types BFSP2-AS1 is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

COAD, BRCA, and LUAD are the cancer types where BFSP2-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BFSP2-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	All	−0.192	<.001	9	view →
BRCA	All	II,III,IV	+0.245	.007	6	view →
LUAD	Female	All	+0.258	<.001	4	view →
HNSC	All	II,III,IV	+0.071	.008	4	view →
THCA	All	All	−0.166	.002	3	view →
KIRC	All	All	+0.032	.011	2	view →
STAD	Male	IV	−0.909	.032	1	view →
LUSC	Female	III,IV	+0.235	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

BFSP2-AS1–COAD

Open the COAD breakdown →